BioNTech SE (BNTX) FCF Margin (2018 - 2025)
BioNTech SE (BNTX) reported FCF Margin of 41.07% for Q4 2025, up 7441.0% on a YoY basis from 0.54% in Q4 2024, and down 23.6% sequentially from 53.76% in Q3 2025.
BioNTech SE (BNTX) FCF Margin (2018 - 2025) Analysis & Trends
BioNTech SE (BNTX) has 8 years of FCF Margin data on file, last reported at 41.07% in Q4 2025.
- For the quarter ending Q4 2025, FCF Margin rose 7441.0% year-over-year to 41.07%; the trailing twelve-month figure through Dec 2025 stood at 24.56% (up 708.0% YoY), and the FY2025 full-year result was 21.99%, up 403.0% from the prior year.
- FCF Margin declined to 41.07% in Q4 2025, from 53.76% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 2655.87% in Q2 2023 to a low of 400.33% in Q1 2025.
- A 5-year average of 201.42% and a median of 33.59% in 2021 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin jumped 253106 bps in 2023 and slumped 132270 bps in 2024, its largest moves.
- Tracing BNTX's FCF Margin over 5 years: stood at 4.32% in 2021, then soared by 423 bps to 22.57% in 2022, then surged by 180 bps to 63.2% in 2023, then slumped by 153 bps to 33.34% in 2024, then surged by 223 bps to 41.07% in 2025.
- Business Quant data shows BNTX's FCF Margin at 41.07% in Q4 2025, 53.76% in Q3 2025, and 66.56% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | BioNTech SE | 22.13 Bn | 22.13 Bn | 668.28 Mn | 41.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41.07% |
| Sep 30, 2025 | 53.76% |
| Jun 30, 2025 | 66.56% |
| Mar 31, 2025 | -400.33% |
| Dec 31, 2024 | -33.34% |
| Sep 30, 2024 | -45.48% |
| Jun 30, 2024 | 1,333.18% |
| Mar 31, 2024 | -137.95% |
| Dec 31, 2023 | 63.20% |
| Sep 30, 2023 | 96.55% |
| Jun 30, 2023 | 2,655.87% |
| Mar 31, 2023 | -49.51% |
| Dec 31, 2022 | 22.57% |
| Sep 30, 2022 | 140.32% |
| Jun 30, 2022 | 124.81% |
| Mar 31, 2022 | 64.23% |
| Dec 31, 2021 | 4.32% |
| Sep 30, 2021 | 26.10% |
| Jun 30, 2021 | 2.38% |
| Mar 31, 2021 | 0.00% |